SMARCB1 and schwannoma: Instead, SMARCB1 mutations located at the ends of the gene, particularly non-truncating alterations, including missense variants, are most frequently associated with non-oncologic diseases and low-grade tumors such as the ones reported in CSS, meningiomas, and schwannomas.